• 1
    Khanna D, Denton CP. Evidence-based management of rapidly progressing systemic sclerosis. Best Pract Res Clin Rheumatol 2010; 24: 387400.
  • 2
    Bernatsky S, Hudson M, Panopalis P, Clarke AE, Pope J, LeClercq S, et al, and the Canadian Scleroderma Research Group. The cost of systemic sclerosis. Arthritis Rheum 2009; 61: 11923.
  • 3
    Hudson M, Steele R, Lu Y, Thombs BD, Canadian Scleroderma Research Group, Baron M. Work disability in systemic sclerosis. J Rheumatol 2009; 36: 24816.
  • 4
    Ouimet JM, Pope JE, Gutmanis I, Koval J. Work disability in scleroderma is greater than in rheumatoid arthritis and is predicted by high HAQ scores. Open Rheumatol J 2008; 2: 4452.
  • 5
    Beaton D, Bombardier C, Escorpizo R, Zhang W, Lacaille D, Boonen A, et al. Measuring worker productivity: frameworks and measures. J Rheumatol 2009; 36: 21009.
  • 6
    Escorpizo R, Bombardier C, Boonen A, Hazes JM, Lacaille D, Strand V, et al. Worker productivity outcome measures in arthritis. J Rheumatol 2007; 34: 137280.
  • 7
    Kavanaugh A, Smolen JS, Emery P, Purcaru O, Keystone E, Richard L, et al. Effect of certolizumab pegol with methotrexate on home and work place productivity and social activities in patients with active rheumatoid arthritis. Arthritis Rheum 2009; 61: 1592600.
  • 8
    Osterhaus JT, Purcaru O, Richard L. Discriminant validity, responsiveness and reliability of the rheumatoid arthritis-specific Work Productivity Survey (WPS-RA). Arthritis Res Ther 2009; 11: R73.
  • 9
    Frech T, Hays RD, Maranian P, Clements PJ, Furst DE, Khanna D. Prevalence and correlates of sleep disturbance in systemic sclerosis: results from the UCLA scleroderma quality of life study. Rheumatology (Oxford) 2011; 50: 12807.
  • 10
    Andresen EM, Malmgren JA, Carter WB, Patrick DL. Screening for depression in well older adults: evaluation of a short form of the CES-D (Center for Epidemiologic Studies Depression Scale). Am J Prev Med 1994; 10: 7784.
  • 11
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 12
    Khanna D, Clements PJ, Postlethwaite AE, Furst DE. Does incorporation of aids and devices make a difference in the score of the Health Assessment Questionnaire-disability index? Analysis from a scleroderma clinical trial. J Rheumatol 2008; 35: 4668.
  • 13
    Cella D, Yount S, Sorensen M, Chartash E, Sengupta N, Grober J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005; 35: 8119.
  • 14
    Agresti A. A categorical data analysis. 2nd ed. New York: Wiley; 2002.
  • 15
    US Department of Labor, Bureau of Labor Statistics. Usual weekly earnings of wage and salary workers second quarter of 2010. 2010. URL:
  • 16
    Minier T, Pentek M, Brodszky V, Ecseki A, Karpati K, Polgar A. Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology (Oxford) 2010; 49: 19208.
  • 17
    Clements PJ, Wong WK, Hurwitz EL, Furst DE, Mayes M, White B, et al. Correlates of the disability index of Health Assessment Questionnaire: a measure of functional impairment in systemic sclerosis. Arthritis Rheum 1999; 42: 237280.